Schroder Investment Management Group
CBPO

Schroder Investment Management Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Schroder Investment Management Group’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-615
Closed -$73K – 1657
2021
Q1 		$73K Sell
615
-69
-10% -$8.16K ﹤0.01% 1412
2020
Q4 		$81K Hold
684
– – ﹤0.01% 1384
2020
Q3 		$76K Sell
684
-500
-42% -$53.7K ﹤0.01% 1251
2020
Q2 		$121K Buy
1,184
+203
+21% +$21.7K ﹤0.01% 1143
2020
Q1 		$97K Sell
981
-117
-11% -$13.4K ﹤0.01% 1189
2019
Q4 		$128K Buy
+1,098
New +$127K ﹤0.01% 1195
2018
Q3 		– Sell
-67,320
Closed -$6.5M – 1376
2018
Q2 		$6.5M Sell
67,320
-61,100
-48% -$5.28M 0.01% 675
2018
Q1 		$10.4M Sell
128,420
-61,500
-32% -$4.97M 0.02% 601
2017
Q4 		$15M Sell
189,920
-826,172
-81% -$68.7M 0.02% 564
2017
Q3 		$92.8M Buy
1,016,092
+471,416
+87% +$45.3M 0.16% 160
2017
Q2 		$60.8M Buy
544,676
+482,175
+771% +$53.9M 0.11% 242
2017
Q1 		$6.25M Buy
+62,501
New +$6.68M 0.01% 689

Schroder Investment Management Group's CBPO Position: Q2 2021 in Review

Schroder Investment Management Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 615 shares — an estimated $73K sold.

Schroder Investment Management Group first reported a position in CBPO in Q1 2017 and held it in 12 quarters. The position peaked at $92.8M in Q3 2017. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Schroder Investment Management Group reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • Schroder Investment Management Group sold 615 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $73K.
  • Schroder Investment Management Group first reported a position in China Biologic Products Holdings, Inc. in Q1 2017 and held it in 12 quarters.
  • Schroder Investment Management Group's China Biologic Products Holdings, Inc. position peaked at $92.8M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Schroder Investment Management Group's 13F filing for Q2 2021, filed 13 Aug 2021.